Efektivitas Penambahan Natrium Diklofenak terhadap Larutan Obat Dilatasi Pupil pada Pasien Retinopati Diabetik
Abstract
Pemeriksaan fundus memerlukan akses visualisasi yang baik. Pada penderita diabetes melitus, pupil sulit lebar menggunakan obat pelebar pupil standar sehingga perlu ditambahkan agen pelebar pupil. Penelitian ini dilakukan di Rumah Sakit Mata Cicendo periode Januari sampai Juli 2014 menggunakan metode double masked rendomized cotrolled trial terhadap 64 mata dari 32 subjek penelitian yang telah didiagnosis menderita retinopati diabetika dengan tingkat yang sama antara mata kiri dan kanan. Dibuat larutan kombinasi campuran 10 mL tropikamid 0,5%/fenilefrin 0,5%, 10 mL fenilefrin 5% dan 10 ml 0,1% Na diklofenak (larutan I) dan campuran 10 mL tropikamid 0,5%/fenilefrin 0,5%, dan 10 mL fenilefrin 5% (larutan II). Setiap subjek mendapat salah satu larutan pada mata dan larutan yang lain pada sebelahnya secara acak. Dilakukan pemantauan dengan cara memotret pupil pada menit ke-15, 20, dan 25 pada kedua mata. Lebar pupil kedua kelompok perlakuan diukur dengan perangkat lunak khusus (image processing). Dari penenelitian terdapat perbedaan bermakna antara penggunaan larutan I dan larutan II dalam melebarkan pupil baik pada menit ke-15 (t=2,02; p=0,047), menit ke 20 (t=2,23; p=0,029), dan pada menit ke-25 (t=2,041; p=0,045). Larutan kombinasi fenilefrin, tropikamid, dan natrium diklofenak menghasilkan efek dilatasi pupil yang lebih baik dibanding dengan larutan kombinasi fenilefrin dan tropikamid saja pada kasus retinopati diabetes. [MKB. 2017;49(3):199–207]
Kata kunci: Dilatasi pupil, natrium diklofenak, retinopati diabetika
Effectiveness of Sodium Diclofenac Addition to Pupil Dilatation Agent on Diabetic Retinopathy Patients
Fundus examination requires good visualization of fundus. In diabetic patients, it is difficult for the pupil to dilate using the standard pupilarry dilating agent. To achieve proper dilation, special agents have to be added to the standard dilation agent. The study was conducted in Cicendo Eye Hospital from January to July 2014, using double masked randomized controlled trial to 32 patients (64 eyes) who were diagnosed as suffering from diabetic retinopathy with the same grade on both eyes. Eye drop solutions were developed beforehand by mixing 10 mL of 0.5% tropicamide/0.5% phenylephrine, 10 mL of 5% phenylephrine, and 10 mL of 0.1% diclofenac-natrium (solution I) and also by mixing 10 mL of 0.5% tropicamide/0.5% phenylephrine and 10 mL of 5% phenylephrine (solution II). Every subject received one drop of one solution on one eye and the other solution on the other eye in randomly fashion. The observation was performed by taking photographs of the pupil on both eyes 15, 20, and 25 minutes of observation. The resulting pupil photographs were then analyzed and measured using special image processing software and compared. It was revealed that there were statistical differences in pupil dilation between solution I and solution II at 15 minutes (t=2.02; p=0.047), 20 minutes (t=2.23, p=0.029), and 25 minutes (t=2.041, p=0.045). Phenilefrine, tropicamide and diclofenac-natrium combination solution provides better dilation effect on the pupil compared to the combination of phenilefrine and tropicamide alone in diabetic retinopathy patient. [MKB. 2017;49(3):199–207]
Key words: Diabetic retinopathy, natrium diclofenac, pupil dilatation
Keywords
Full Text:
PDFReferences
Lin JC, Shau WY, Lai MS. Sex- and age-specific prevalence and incidence rates of sight-threatening diabetic retinopathy in Taiwan. JAMA Ophthalmol. 2014;132(8):922–8.
Xu J, Xu L, Wang YX, You QS, Jonas JB, Wei WB. Ten-year cumulative incidence of diabetic retinopathy. The Beijing Eye Study 2001/2011. PLoS One. 2014;9(10):e111320.
Lee DJ, Kumar N, Feuer WJ, Chou CF, Rosa PR, Schiffman JC, dkk. Dilated eye examination screening guideline compliance among patients with diabetes without a diabetic retinopathy diagnosis: the role of geographic access. BMJ Open Diabetes Res Care. 2014; 2(1):e000031.
Rim TH, Byun IH, Kim HS, Lee SY, Yoon JS. Factors associated with diabetic retinopathy and nephropathy screening in Korea: the Third and Fourth Korea National Health and Nutrition Examination Survey (KNHANES III and IV). J Korean Med Sci. 2013;28(6):814–20.
Preti RC, Motta AA, Maia OO, Jr., Morita C, Nascimento VP, Monteiro ML, dkk. Relationship between diabetic retinopathy severity and the timespan between the endocrinopathy diagnosis and the first ophthalmic examination. Arq Bras Oftalmol. 2010;73(3):240–3.
McCannel CA. Improved intraoperative fundus visualization in corneal edema: the viscoat trick. Retina. 2012;32(1):189–90.
Punyawattanaporn A, Tengtrisorn S, Sangsupawanich P. Pupil dilatation after single and triple doses of mydriatic agent in preterm infants. J Med Assoc Thai. 2009;92(11):1458–62.
Trinavarat A, Pituksung A. Effective pupil dilatation with a mixture of 0.75% tropicamide and 2.5% phenylephrine: a randomized controlled trial. Indian J Ophthalmol. 2009;57(5):351–4.
Ong-Tone L, Bell A. Pupil size with and without adrenaline with diclofenac use before cataract surgery. J Cataract Refract Surg. 2009;35(8):1396–400.
Hirowatari T, Tokuda K, Kamei Y, Miyazaki Y, Matsubara M. [TPD ophthalmic solution (mixture of tropicamide, phenylephrine hydrochloride, and diclofenac sodium) for cataract surgery]. Nippon Ganka Gakkai Zasshi. 2002;106(10):630–3.
Ostrin LA, Glasser A. The effects of phenylephrine on pupil diameter and accommodation in rhesus monkeys. Invest Ophthalmol Vis Sci. 2004;45(1):215–21.
Tokuda K, Hirowatari T, Kamei Y, Miyazaki Y, Matsubara M. Availability of TPD ophthalmic solution (mixture of mydrin-P solution, neosynesin kowa solution, and diclod solution) in regard to the corneal barrier function--clinical evaluation for vitrectomy in patients with diabetic retinopathy]. Nippon Ganka Gakkai Zasshi. 2002;106(10):648–53.
Hossain MM, Mohiuddin AA, Hossain MA, Aziz MA. Diclofenac sodium and prednisolone acetate ophthalmic solution in controlling inflammation after cataract surgery. Mymensingh Med J. 2010;19(3):343–7.
Ratanapakorn T, Yospaiboon Y, Chaisrisawadsuk N. Single dose of 1% tropicamide and 10% phenylephrine for pupil dilation. J Med Assoc Thai. 2006;89(11): 1934–9.
Evcim AS, Micili SC, Karaman M, Erbil G, Guneli E, Gidener S, dkk. The role of rac1 on carbachol-induced contractile activity in detrusor smooth muscle from streptozotocin-induced diabetic rats. Basic Clin Pharmacol Toxicol. 2015;116(6):476–84.
Erken HA, Genc O, Erken G, Ayada C, Gundogdu G, Dogan H. Ozone partially prevents diabetic neuropathy in rats. Exp Clin Endocrinol Diabetes. 2015;123(2):101–5.
Lee J, Lee HI, Seo KI, Cho HW, Kim MJ, Park EM, dkk. Effects of ursolic acid on glucose metabolism, the polyol pathway and dyslipidemia in non-obese type 2 diabetic mice. Indian J Exp Biol. 2014;52(7):683–91.
Aleo CL, Murchison AP, Dai Y,, Hark LA, Mayro EL, Collymore B, dkk. Improving eye care follow-up adherence in diabetic patients with ocular abnormalities: the effectiveness of patient contracts in a free, pharmacy-based eye screening. Public Health. 2015;129(7):996–9.
Mao X, Zhang S, Hen H, Du L, Li G, Li B, dkk. Corneal permeability assay of topical eye drop solutions in rabbits by MRI. J Huazhong Univ Sci Technolog Med Sci. 2010;30(6): 804–8.
Loftsson T, Stefansson E. Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye. Acta Ophthalmol Scand. 2002;80(2):144–50.
DOI: https://doi.org/10.15395/mkb.v49n3.1122
Article Metrics
Abstract view : 1077 timesPDF - 1479 times
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
MKB is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
View My Stats